LifeCell International is a prominent Indian biotechnology company founded in 2004, primarily known for its extensive work in stem cell banking and related healthcare services. Company OverviewFoundation: Established in 2004, LifeCell International has become India's largest stem cell bank and is recognized as the third-largest globally.Core Services: The company specializes in umbilical cord blood stem cell banking, diagnostics, and tissue therapeutics. It aims to provide preventive healthcare services that enhance family wellness
Checking authentication...
Checking authentication...
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 170.75 | 137.16 | 166.92 | - |
| Cost of Material Consumed | - | - | - | - |
| Gross Margins | - | - | - | - |
| Change in Inventory | - | - | - | - |
| Employee Benefit Expenses | - | - | - | - |
| Other Expenses | - | - | - | - |
| EBITDA | 14.11 | -22.62 | 92 | - |
| OPM | - | - | 0.5512 | - |
| Other Income | - | - | - | - |
| Finance Cost | - | - | - | - |
| D&A | - | - | - | - |
| EBIT | - | - | - | - |
| EBIT Margins | - | - | - | - |
| PBT | 107.31 | -12.23 | 92 | - |
| PBT Margins | 0.3715 | -0.0455 | 0.5512 | - |
| Tax (2021) | - | - | - | - |
| PAT | 107.31 | -11.56 | 92 | - |
| NPM | 0.3715 | -1.0843 | 0.5512 | - |
| EPS | - | - | - | - |
| Financial Ratios | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | - | - | - | - |
| Net Profit Margin | 0.3715 | -0.0455 | 0.5512 | - |
| Earning Per Share (Diluted) | - | - | - | - |
| Promoters | Designation | Experience | Linkedin Profile |
|---|---|---|---|
| Aishwarya Rai Bachchan | Brand Ambassador | - | - |
| Anjali Keshavprasad Srivastava | Customer Success Manager | 5+ | - |
| Kiruthiga P | Marketing Executive | 3 | - |
Access essential information and documents to make informed investment decisions
Stay updated with upcoming events, conferences, and announcements
Access quarterly and half-yearly financial statements and reports
Download comprehensive annual reports and financial summaries
Access investor presentations, corporate briefings, and slideshows
The current market price of Lifecell International unlisted shares is ₹550 per share.
The minimum lot size is ₹20000.0 shares, and trades must be placed in multiples of this.
The shares have traded as high as ₹550 and as low as ₹400 over the past year.
The shares are held in NSDL&CDSL depositories under ISIN INE313W03027.
Lifecell International Shares's market capitalization is approximately 1073 crore.
The company has P/E ratio of ₹9.4, P/B ratio of 4.84, Debt-to-Equity ratio of 0, ROE of 37.15%.
The book value of Lifecell International Shares is ₹113.55 per share.
The face value of Lifecell International unlisted shares is ₹10.0 per share.
Lifecell International Shares has 18353856 shares outstanding.
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
Discover a variety of unlisted shares beyond the popular picks. Stay updated with real-time pricing, emerging opportunities, and market trends to diversify your portfolio and make confident investment decisions.
₹11
₹435
.avif&w=256&q=75)
₹3200
.avif&w=256&q=75){kind=logo}
₹405
.avif&w=256&q=75){kind=logo}
₹775
₹465
